# Congenital Adrenal Hyperplasia Once Daily Hydrocortisone Treatment

> **NCT03760835** · PHASE4 · RECRUITING · sponsor: **Federico II University** · enrollment: 150 (estimated)

## Conditions studied

- Congenital Adrenal Hyperplasia

## Interventions

- **DRUG:** Conventional Glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone)
- **DRUG:** Dual release hydrocortisone (plenadren)

## Key facts

- **NCT ID:** NCT03760835
- **Lead sponsor:** Federico II University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2016-08-11
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2025-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03760835

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03760835, "Congenital Adrenal Hyperplasia Once Daily Hydrocortisone Treatment". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03760835. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*